Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus: A Randomized Controlled Open-label Study

NCT01374854 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.

NCT NCT01374854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01374854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus: A Randomized Controlled Open-label Study
Lead sponsor
Fuzhou General Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2014
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus